NORAD contributes to cancer development, and its expression is upregulated and associated with poor prognosis in various types of cancers, including colorectal cancer, pancreatic cancer, breast cancer, esophageal squamous cell carcinoma and bladder cancer [106,107,108,109,110,111,112]. Here, NORAD is linked to cancer.